Although the biological behavior, recurrence rate, and PTCH mutation were the main reasons for the WHO consensus in 2005 to shift towards neoplasm, it was not unanimous owing to inadequate genetic and molecular evidence. The gene discussed is PTCH1; the disease is neoplasm.